As COVID19 Hospitalizations Climb a new Vaccine emerges

Donate Twitter Facebook LinkedIn


The Moderna SPIKEVAX COVID-19 vaccine targeting the Omicron XBB.1.5 variant meets Canada’s health department’s stringent safety, efficacy and quality requirements for people six months of age and older said a release on Tuesday.

Numbers of Infections and Hospitalizations are Climbing again

“We are absolutely encouraging people to get protected both with COVID-19 vaccine and the flu shot,” Canada’s Chief Public Health Officer Theresa Tam said during a news conference.

“Health Canada is also actively reviewing submissions from Pfizer-BioNTech seeking authorization of their COVID-19 vaccine targeting the Omicron XBB.1.5 subvariant for people six months of age and older. In addition, Health Canada has received a submission from Novavax for their COVID-19 vaccine targeting the Omicron XBB.1.5 subvariant for people 12 years and older. These submissions are being reviewed on a priority basis by dedicated scientific teams,” the department release explained on Tuesday.

“Unequivocal evidence indicates that all of the vaccines used in Canada are very effective at preventing severe illness, hospitalization and death from SARS-COV-2 which causes COVID-19,” explained Dr. Fred Harris the team-leader of the CSPaC biostatistical group in Singapore. “The data speaks for itself. Get vaccinated or suffer more, while risking possible serious illness and even in the some cases where comorbid indications exist, death.”

“Since vaccine protection decreases over time,” notes Health Canada, “if it has been six months since your last dose, vaccination with the new formulation of COVID-19 vaccine is recommended to provide better protection against variants of concern.”

Another aspect, suggested by Dr. Harris is the “risk of allowing the disease to spread across more hosts and thus inviting the virus to spawn more variants including those which may be able to escape the antibodies produced by the human body and become more lethal.”

United States of America COVID-19 Hospitalizations On the Rise

USA COVID19 HospitalizationsCOVID-19 Hospitalizations in United States of America. Source CSPaC.

Canada COVID-19 Hospitalizations On the Rise

Canada COVID19 Hospitalizations
COVID-19 Hospitalizations in Canada Source CSPaC.

2 Dec 2023 COVID-19 Data for The Entire World from CSPaC

255 Locales report 698,375,144 COVID-19 cases and 6,964,273 fatalities.

GMT 2023-12-02 03:32

Data reported should be in accordance with the applied case definitions and testing strategies in each locale as their governments report daily or from time to time. All data researched and published by The RINJ Foundation and partners in CSPaC.

©The RINJ Foundation 2020-2023-12-02 / 03:32:15Z Singapore-SK-HUK-77
RINJ is with Civil Society Solidarity Partners against COVID-19.

SARS2 Update 2023-12-02 03:32 GMT

  • Global Population: 7,991,055,500
  • 255 Regions reported 698,375,144 cases
  • 63,212,345 cases active
  • 6,964,273 people reported killed by COVID-19
  • 0.95% is current Case Fatality Rate (CFR)
  • 631,397,935 survived COVID-19
Beta Technology Global Estimates
  • 0.49% Global estimated inferred average Infection Fatality Rate (IFR)
    (influenza is .1% or 6 per 100k (2019))
  • 18,796,224 Total deaths (CSPaC.net estimated actual) including errors, unexpected deaths with pneumonia indications with no history, and unreported likely-cause excess deaths such as people who never went to a hospital but had COVID-19 indications but never tested.

    • See The Lancet estimate of excess mortality from COVID-19 (Download PDF) in 191 countries/territories and 252 subnational units of select countries, from 1 January 2 0 2 0, to 31 December 2 0 2 1.

    USA (109,563,146)
    • 177.99% of the USA may have been infected including reported + estimated unreported mild and estimated asymptomatic (594,070,950.55) persons, some of whom may not have been ill in their first course of the disease, but could have spread the disease.
    • 1.09% is USA current Case Fatality Rate (CFR)&
    • 0.25% is estimated inferred average Infection Fatality Rate (IFR)
    • 1,485,177 estimated total COVID-19 deaths including unreported likely-cause excess deaths. According to projections of IHME, IHME calculation of excess deaths is slightly higher than what CSPaC is showing.

    See The Lancet estimate of excess mortality from COVID-19 (Download PDF) in 191 countries/territories and 252 subnational units of select countries, from 1 January 2 0 2 0, to 31 December 2 0 2 1.

    The American Epicenter has 0.59 % of global 'active' cases (921,578 USA / 156,397,557 Global), people infected with COVID-19 now.

    Below: CSPAC estimated 2023-11-30 23:03 GMT COVID-19 data for India.

    EPICENTER-2: India (45,001,944)

    Reported*Cases*Deaths*CFR*Recovered
    India45,001,944533,2981.2%0
    *Reported by India but understated.

    Note: India's reported death sum and cured data are widely seen among epidemiologists and biostatisticians as unreliable. For example, 3,093,075 is CSPAC estimated sum of deaths while India reports 533,298, creating the largest discepency in the world. India might only report hospital tested cases. Sources among hundreds of nurses and other medical practitioners provide a picture that in summary concludes most cases never present in a hospital especially in northern provinces where health care is less available and utilization is low anyway because of poverty, hence most people die at home in India. This theory could explain discrepancies between reported data and algorithmic estimates.

    LocaleCasesDeathsActive
    India reported:45,001,944533,29844,468,646
    India estimates:248,860,7503,093,075245,767,675

    Data collected and reported by: Civil Society Solidarity Partners against COVID-19